NFE2L2 and Alzheimer disease: Acrolein has been proposed to be involved in AD etiology, with the efficacy of CR mediated, at least partly, through the amelioration of acrolein-induced depletion of hippocampal SOD levels, indicating a positive effect of this protocol on Nrf2 signaling (Huang Y.J. et al., 2018).